• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

R1 Completes Acquisition of SCI Solutions

Share:

April 6, 2020

R1 RCM Inc. (NASDAQ:RCM), a leader in technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced it has completed the acquisition of SCI Solutions, Inc. (SCI).

The combination of R1 and SCI is expected to deliver enhanced value for healthcare providers by enabling them to expand digital front door strategies for their patients, improve operating efficiency, and increase capacity utilization, among other benefits. R1 has made substantial progress toward the planning of a successful integration and anticipates integration efforts to begin shortly.

“We are pleased to complete the acquisition of SCI and look forward to building on the advanced capabilities they have developed,” said Joe Flanagan, President and CEO of R1. “With this combination, we believe R1 offers healthcare providers the broadest and deepest tech-enabled patient intake solution on the market.”

Source: BioSpace

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Health Plans Must Go Beyond the ONC Mandate and Prioritize Member ExperienceHealth Plans Must Go Beyond the ONC Mandate and Prioritize Member Experience
  • Joe Kvedar, MD, New President-Elect of the ATAJoe Kvedar, MD, New President-Elect of the ATA
  • Clinical Trial Management Company ClinOne Scores $3.6MClinical Trial Management Company ClinOne Scores $3.6M
  • AstraZeneca to Acquire Gracell, Furthering Cell Therapy Ambition Across Oncology and Autoimmune DiseasesAstraZeneca to Acquire Gracell, Furthering Cell Therapy Ambition Across Oncology and Autoimmune Diseases
  • Jazz Pharmaceuticals Announces Acquisition of Cavion, Inc.Jazz Pharmaceuticals Announces Acquisition of Cavion, Inc.
  • Carl Icahn drops opposition to Express Scripts-Cigna mergerCarl Icahn drops opposition to Express Scripts-Cigna merger
  • Air Force Invests $1.3 Million To Help Military Couples ConceiveAir Force Invests $1.3 Million To Help Military Couples Conceive
  • AliveCor Lands $65M to Advance Remote Cardiology Platform WorldwideAliveCor Lands $65M to Advance Remote Cardiology Platform Worldwide

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications